R56 NS127391/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	2
2024	1
2025	0

Page 1

Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses.

Park TY, Jeon J, Cha Y, Kim KS. Park TY, et al. Cell Res. 2024 Jul;34(7):479-492. doi: 10.1038/s41422-024-00971-y. Epub 2024 May 22. Cell Res. 2024. PMID: 38777859 Free PMC article. Review.

An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.

Kim W, Tripathi M, Kim C, Vardhineni S, Cha Y, Kandi SK, Feitosa M, Kholiya R, Sah E, Thakur A, Kim Y, Ko S, Bhatia K, Manohar S, Kong YB, Sindhu G, Kim YS, Cohen B, Rawat DS, Kim KS. Kim W, et al. Nat Commun. 2023 Jul 18;14(1):4283. doi: 10.1038/s41467-023-39970-9. Nat Commun. 2023. PMID: 37463889 Free PMC article.

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.

Cha Y, Park TY, Leblanc P, Kim KS. Cha Y, et al. J Mov Disord. 2023 Jan;16(1):22-41. doi: 10.14802/jmd.22141. Epub 2023 Jan 12. J Mov Disord. 2023. PMID: 36628428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year